Brief: Spago Nanomedical Q2 Sales SEK 459 Thousand

Spago Nanomedical AB (publ)

21/08/2024 07:00

Aug 21 (Reuters) - Spago Nanomedical Q2 adjusted EPS SEK -0.03.
* Q2 operating expenses SEK -10.255 million
* Q2 net income SEK -8.152 million